Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Study of SynKIR-310, Autologous T Cells Transduced With CD19 KIR-CAR, in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06544265
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:55.506306+00:00
Published At
2026-04-14T00:00:00+00:00
Record Updated At
2026-04-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["B Cell Lymphoma", "NHL, Adult", "Mantle Cell Lymphoma", "Relapsed Non-Hodgkin Lymphoma", "Refractory Non-Hodgkin Lymphoma", "Aggressive B-Cell Non-Hodgkin Lymphoma", "Indolent B-Cell Non-Hodgkin Lymphoma", "Follicular Lymphoma", "Marginal Zone Lymphoma", "DLBCL - Diffuse Large B Cell Lymphoma", "HGBL With MYC and BCL2 and/or BCL6 Rearrangements", "High-grade B-cell Lymphoma", "Diffuse Large B Cell Lymphoma", "Large B-cell Lymphoma", "T-Cell/Histiocyte Rich Lymphoma", "Non-hodgkin Lymphoma,B Cell", "Primary Mediastinal Large B-cell Lymphoma (PMBCL)", "Epstein-Barr Virus Positive DLBCL, Nos", "Follicular Lymphoma Grade 3B", "DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation", "High Grade B-Cell Lymphoma, Not Otherwise Specified", "Follicular Lymphoma Grade 3", "Marginal Zone Splenic Lymphoma", "DLBCL", "Waldenstrom Macroglobulinemia", "Waldenstrom Macroglobulinaemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-14"
protocolSection.identificationModule.nctId
"NCT06544265"
protocolSection.identificationModule.officialTitle
"A Phase 1 Study of SynKIR-310, Autologous T Cells Transduced With CD19 KIR-CAR, in Participants With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • B Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • NHL, Adult (protocolSection.conditionsModule.conditions)
  • Mantle Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Relapsed Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Aggressive B-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Indolent B-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Follicular Lymphoma (protocolSection.conditionsModule.conditions)
  • Marginal Zone Lymphoma (protocolSection.conditionsModule.conditions)
  • DLBCL - Diffuse Large B Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • HGBL With MYC and BCL2 and/or BCL6 Rearrangements (protocolSection.conditionsModule.conditions)
  • High-grade B-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Diffuse Large B Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Large B-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • T-Cell/Histiocyte Rich Lymphoma (protocolSection.conditionsModule.conditions)
  • Non-hodgkin Lymphoma,B Cell (protocolSection.conditionsModule.conditions)
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL) (protocolSection.conditionsModule.conditions)
  • Epstein-Barr Virus Positive DLBCL, Nos (protocolSection.conditionsModule.conditions)
  • Follicular Lymphoma Grade 3B (protocolSection.conditionsModule.conditions)
  • DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation (protocolSection.conditionsModule.conditions)
  • High Grade B-Cell Lymphoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)
  • Follicular Lymphoma Grade 3 (protocolSection.conditionsModule.conditions)
  • Marginal Zone Splenic Lymphoma (protocolSection.conditionsModule.conditions)
  • DLBCL (protocolSection.conditionsModule.conditions)
  • Waldenstrom Macroglobulinemia (protocolSection.conditionsModule.conditions)
  • Waldenstrom Macroglobulinaemia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.